Dear John,

Join us this Wednesday April 23 for an exclusive Insider virtual event exploring site-neutral payments with health economist and health services researcher Brady Post of Northeastern University and Health Affairs' Meg Winchester.

As an Insider, you get access to these exclusive events and so much more. Become an Insider today.

This week, President Trump signed an executive order that changes the "pill penalty" provision of the Medicare drug price negotiations.

For this week's Flashback Friday, let's take a look back at what Health Affairs has published on the subject of Medicare drug price negotiations.

Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations

Laura Tollen (August 2024)

The First-Ever Government Negotiation Process For Drugs Has Finished, But The Politics Are Ongoing

Tricia Neuman et al. (August 2024)

Medicare Drug Price Negotiations: Policy Implications Of The First 10 Drugs’ Features

Nitzan Arad et al. (April 2024)

Setbacks For Pharmaceutical Industry In Challenges To Medicare Drug Price Negotiations

Zachary Baron and Sheela Ranganathan (March 2024)

Medicare Drug Price Negotiations: A Principles-Based Guide For CMS

Anirban Basu et al. (June 2023)

A Peek Behind the Medicare Drug Price Negotiation Curtain

Jeff Byers and Ellen Bayer (August 2024)

Published Today

Whether Health Care M&A is Cooked Or Not w/ Bob Herman

Health Affairs' Jeff Byers welcomes Bob Herman of STAT News to the program to discuss the state of deals in the health care space, how vertical integration and consolidation have played a role in mergers & acquisitions as it relates to hospitals, and what might fly under the radar from even the most savvy of health policy wonks.

The Clinical Consequences Of Kennedy V. Braidwood

Robert M. Zimbroff et al.